• ID NOW EUA SARS-CoV-2 assay had an overall agreement of 78.7% when compared to the standard of care reference methods. • ID NOW had a sensitivity of 71.7% and specificity of 100%. • All the false-negative results occurred with weakly positive samples, with reference method C(T) values ≥35.